help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2336
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/6/2072    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Hew-Butler, T.
Right arrow Articles by Verbalis, J. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hew-Butler, T.
Right arrow Articles by Verbalis, J. G.
Related Collections
Right arrow Neuroendocrinology and Pituitary
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 6 2072-2078
Copyright © 2008 by The Endocrine Society

Osmotic and Nonosmotic Regulation of Arginine Vasopressin during Prolonged Endurance Exercise

Tamara Hew-Butler, Esme Jordaan, Kristin J. Stuempfle, Dale B. Speedy, Arthur J. Siegel, Timothy D. Noakes, Steven J. Soldin and Joseph G. Verbalis

Department of Human Biology, University of Cape Town (T.H.-B., T.D.N.), 7701 Cape Town, South Africa; Biostatistics Unit, Medical Research Council (E.J.), Biostatistics Unit, South Africa; Health Sciences Department, Gettysburg College (K.J.S.), Gettysburg, Pennsylvania 17325; Department of General Medicine and Primary Care, University of Auckland (D.B.S.), 1142 Auckland, New Zealand; Department of Medicine, Harvard Medical School (A.J.S.), Boston, Massachusetts 02114; and Bioanalytical Care Laboratory, General Clinical Research Center (S.J.S.) and Department of Endocrinology and Metabolism (J.G.V.), Georgetown University Medical Center, Washington, D.C. 20057

Address all correspondence and requests for reprints to (present address): Tamara Hew-Butler, D.P.M., Ph.D., Systemic Inflammation Lab, Trauma Research, St. Joseph’s Hospital and Medical Center, 350 West Thomas Road, Phoenix, Arizona 85013. E-mail: tamara.hew{at}chw.edu.

Context: Although the primary cause of exercise-associated hyponatremia (EAH) is relative overconsumption of fluids beyond the kidneys’ ability to excrete excess fluid, the mechanisms limiting maximum renal excretory ability during exercise remain to be elucidated.

Objective: The objective of the study was to: 1) perform a comprehensive evaluation of the endocrine secretion of pituitary, natriuretic and adrenal steroid hormones, and cytokines immediately before and after running an ultramarathon; and 2) evaluate the relationship between osmotic and nonosmotic stimuli to arginine vasopressin (AVP) secretion within the overall context of assessing the hormonal regulation of fluid balance during prolonged endurance exercise.

Design: This was an observational study.

Setting: The study setting was a 56-km ultramarathon.

Participants: Eighty-two runners participated in the study.

Interventions: There were no interventions.

Main Outcome Measures: Plasma sodium concentration [Na+] and plasma volume [(AVP)p] were measured.

Results: Fluid homeostasis during exercise (356 ± 4 min) was maintained with ad libitum fluid intakes. [Na+] was maintained from before the race (139.3 ± 0.3 mmol/liter) to after the race (138.1 ± 0.4 mmol/liter) with a significant decrease in plasma volume (–8.5 ± 0.1%, P < 0.01). Increases in the plasma (AVP)p (3.9-fold), oxytocin (1.9-fold), brain natriuretic peptide (4.5-fold), and IL-6 (12.5-fold) were highly significant (P < 0.0001). Changes in brain natriuretic peptide, oxytocin, and corticosterone were associated with 47% of the variance noted in (AVP)p and 13% of the variance in plasma [Na+] in pathway analyses.

Conclusions: (AVP)p was markedly elevated after the ultramarathon despite unchanged plasma [Na+]. Therefore, an inability to maximally suppress (AVP)P during exercise as a result of nonosmotic stimulation of AVP secretion may contribute to the pathogenesis of exercise-associated hyponatremia if voluntary fluid intake were to exceed fluid output.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society